6:19 PM
 | 
Apr 24, 2007
 |  BC Extra  |  Company News

Wyeth gets Viviant approvable letter

WYE received an approvable letter from FDA for Viviant bazedoxifene to prevent postmenopausal osteoporosis. WYE, which said...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >